Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) CEO Phillip L’Huillier talked with Proactive's Stephen Gunnion about the company's latest clinical and...
IXICO PLC (LSE:IXI, OTC:PHYOF) imaging platform upgrade and two technology partnerships support...
What the company does AIM-listed Scancell Holdings PLC's (LON:SCLP) primary focus is...
ConvaTec Group PLC (LSE:CTEC), the FTSE 100 medical products manufacturer, has retained a 'buy'...
AstraZeneca PLC (LSE:AZN, NYSE:AZN), the FTSE 100 pharmaceuticals group, has received fresh...
Applied Nutrition PLC (LSE:APN) price target rose to 370p from 350p at Deutsche Bank, which...
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) CEO Phillip L’Huillier talked with Proactive's Stephen Gunnion about the company's latest clinical and regulatory progress, including FDA RMAT designation for its lead melanoma treatment, inzitagene plasmivec (iSCIB1+), updated survival data and...